Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

374 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Completed

Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

NCT05671835

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • The Kirklin Clinic of University of Alabama Birmingham Hospital Birmingham, Alabama, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine (UCI) Health Orange, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

NCT04614441

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Chang-Hua Christian Hospital Changhua, Taiwan
  • Chang Gung Memorial Hospital Chiayi Chiayi City, Taiwan
  • National Taiwan University Hospital-Hsin-Chu Branch Hsinchu, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
View all 26 locations
View Trial Details
Completed

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

NCT05255991

Conditions
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Diseases, +3 more
Locations
  • CINME S.A. - Centro de Investigaciones Metabolicas Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Centro Medico Dra. De Salvo Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Instituto Ave Pulmo - Fundación enfisema Mar del Plata, Buenos Aires, Argentina
  • Sanatorio Allende S.A. Córdoba, Córdoba Province, Argentina
View all 108 locations
View Trial Details
Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).

NCT05513950

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • PHI University Clinic of Pulmonology and Allergology Skopje, North Macedonia
  • Medical Center of Limited Liability Company "Arensia Exploratory Medicine", department of Clinical Trials Kyiv, Ukraine
  • Queen Elizabeth Hospital - NIHR Birmingham Clinical Research Facility - University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Royal Papworth Hospital NHSFT - Cambridge Biomedical Campus Cambridge, United Kingdom
View Trial Details
Completed

A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

NCT05954988

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Agaplesion Evangelisches Krankenhaus Mittelhessen Giessen, Germany
View Trial Details

Related conditions